Prevention of Amyloid-β Fibril formation using antibodies against the C-terminal region of Amyloid-β1-40 and Amyloid-β1-42.

26/03/2013

Autores: María Montañés, Diego Casabona, Leticia Sarasa, Pedro Pesini and Manuel Sarasa *Araclon Biotech, CIBIR Laboratory, Logroño, Spain - Araclon Biotech, Montecanal Laboratory, Zaragoza, Spain

Referencia: Journal of Alzheimer’s Disease 34 (2013) Short Communication, 133–137 DOI 10.3233/JAD-120850 IOS Press